1. Management of immune effector cell-associated neurotoxicity syndrome (ICANS);Rees JH,2022
2. Severe cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome in a man receiving immune checkpoint inhibitors for lung cancer;Tanaka T;Intern Med,2024
3. Glofitamab-GXBM (intravenous route). (2024). https.//www.mayoclinic.org/drugs-supplements/glofitamab-gxbm-intravenous-route/description/drg-20552467#:~:text=Descr....
4. Product monograph including patient medication information Prcolumvi® glofitamab for injection concentrate for solution for intravenous infusion. (2023). https.//assets.roche.com/f/173850/x/f54500f377/columvi_pm_e.pdf.
5. Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management;Pennisi M;Blood Adv,2020